Loading...
Investigation of Pump Compatibility of Fast-Acting Insulin Aspart in Subjects With Type 1 Diabetes
BACKGROUND: Ultra-fast-acting insulins, such as fast-acting insulin aspart (faster aspart), have pharmacokinetic properties that may be advantageous for patients using continuous subcutaneous insulin infusion (CSII), provided that they are compatible with and safe to use in CSII. METHODS: Randomized...
Saved in:
Published in: | J Diabetes Sci Technol |
---|---|
Main Authors: | , , , , , |
Format: | Artigo |
Language: | Inglês |
Published: |
SAGE Publications
2017
|
Subjects: | |
Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5761985/ https://ncbi.nlm.nih.gov/pubmed/28918652 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1932296817730375 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|